• BX Home
  • Eli Lilly and Company: News [Page 10]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ELI LILLY AND COMPANY

Eli Lilly and Company, a global pharmaceutical company, is one of the world’s larget corporations. The company develops medicines for a variety of health problems, including Zyprexa, for pancreatic cancer; antidepressant Cymbalta and Prozac; Evista, for osteoporosis; Humalog insulin, and Cialis for erectile dysfunction. The company was founded in 1876 and is based in Indianapolis, Indiana.

Eli Lilly and Company is part of Business Exchange, suggested by Ginny Moore. This topic contains 690 news and 126 blog items. Read updated news, blogs, and resources about Eli Lilly and Company. Find user-submitted articles and reactions on Eli Lilly and Company from like-minded professionals.

News

Please add new articles to this topic

Dow Closes Down 140 Pointsmore

0.2% following the banks better-than-expected first-quarter earnings and declining net credit losses. Revenue fell shy...

Weaker Dollar Aids Drug-Makers' Salesmore

Major U.S. drug makers including Pfizer Inc. and Eli Lilly & Co. are flying against some strong headwinds: patent...

S&P outlook revision hits US equitiesmore

Extract not available.

Drugmaker Eli Lilly's 1Q sales growth at a glancemore

Drugmaker Eli Lilly and Co. said Monday that its first-quarter earnings fell 15 percent due mainly to some one-time...

Lilly Declares Second-Quarter 2011 Dividendmore

/PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the second...

Summary Box: Lilly's 1Q profit falls 15 percentmore

PROFIT FALLS: Drugmaker Eli Lilly and Co.'s first-quarter net income fell 15 percent to $1.06 billion, or 95 cents per...

Stocks Post Biggest Drop in Monthmore

following the banking giant's better-than-expected first-quarter earnings and declining net credit losses.

U.S. Stocks Post Biggest Drop in Monthmore

following the banking giant's better-than-expected first-quarter earnings and declining net credit losses.

Amylin Brings On The Pain With Earningsmore

Amylin Pharmaceuticals posted a first quarter loss Monday of $37.3 million. Eli Lilly reports, too. Amylin...

S&P downgrade hits US equitiesmore

Extract not available.

LLY CFO on Medical Innovationmore

Insight on bringing new products to market, and whether Eli Lilly is interested in M&A, with Erica Rice, Eli Lilly...

A.M. Vitals: Synthes Purchase Would Boost J&J���s Device Businessmore

now we know there���s a better gift for [Valentine's Day] than chocolates.��� It���s Earnings Season: Eli Lilly���s...

Updates, advisories and surprisesmore

KeyCorp swings to $173 million profit (6:55 AM ET) LONDON (MarketWatch) -- Cleveland-based bank KeyCorp (NYSE:KEY) Eli...

Before the Bell: Citigroup, Eli Lilly, Europe in the spotlightmore

banks��� reserve-requirement ratio over the weekend, while a stronger yen pressured Japanese shares. Citigroup (NYSE:C)...

Stocks to Watch: Citigroup, Halliburton, Gap, Kraft and More!more

roughly on par with its large-cap peers. Shares fell 1.8% to $32.77 in light premarket trading. Eli Lilly & Co.

Morning Earnings Roundup: Eli Lilly, TD Ameritrade, Halliburton, KeyCo...more

American unconventional oil fields more than offset impacts from political unrest in North Africa and delays in Iraq.

Citigroup, Eli Lilly, Europe in the spotlightmore

banks�� reserve-requirement ratio over the weekend, while a stronger yen pressured Japanese shares. Citigroup (NYSE:C)...

Earnings deluge awaits investorsmore

earned a year ago.Other names reporting on Monday include newspaper chain Gannett (GCI, Fortune 500), pharmaceutical...

U.S. stocks ready for barrage of earningsmore

of bank failures to 34, according to the Federal Deposit Insurance Corp. Other quarterly reports on deck from Eli...

U.S. stocks ready for barrage of earningsmore

of bank failures to 34, according to the Federal Deposit Insurance Corp. Other quarterly reports on deck from Eli...

High achievers: UCC graduates awarded for outstanding achievementmore

first UCC graduate to be appointed to the country?s highest judicial court and senior vice-president of pharmaceutical...

UPDATE 3-Lilly, Amylin diabetes drug wins EU recommendationmore

* Bydureon recommended for type-2 diabetes in adults * Eli Lilly, Amylin and Alkermes are partners on drug *...

UPDATE 1-Lilly, Amylin diabetes drug wins EU recommendationmore

for Novo's daily Victoza (Adds details, background) LONDON, April 15 (Reuters) - An experimental diabetes medicine from...

EU medicines agency backs Bydureon, Pradaxamore

new medicines adopted * Bydureon (exenatide), from Eli... Positive opinions for new medicines adopted * Bydureon...

UPDATE 1-US regulators turn down Lilly pancreas drugmore

U.S. regulators declined to approve a drug from Eli Lilly and Co (LLY.N) that would help certain pancreatic patients...

Top Sources: Eli Lilly and Company

  • allheadlinenews.com
  • Motley Fool
  • Reuters
  • blogs.wsj.com
  • CNN Money
  • Wall Street Journal Online
  • TheStreet.com
  • MarketWatch
  • outsourceportfolio.com
  • fool.com

Most Active Users in this Topic

see all contributors in Eli Lilly and Company

Featured White Papers

Post a Job

Jobs in this Topic

Consultant Global Medical Education ELI Lilly and Company | Indianapolis, IN
Posted: May 18
Senior Medical Director ELI Lilly | Bridgewater, NJ
Posted: May 18
Associate Financial Advisor Elfcu (eli Lilly Federal Credit Union) | Indianapolis, IN
Posted: May 9
IT Technical Lead- Intelligence Platform (749BR) ELI Lilly | Indianapolis, IN
Posted: May 18
Engineer - Devices PM ELI Lilly | Indianapolis, IN
Posted: May 19

Report comment contains invalid characters. ()
cancel
Search Cancel